ClinicalTrials.Veeva

Menu

iCaReMe Global Registry

AstraZeneca logo

AstraZeneca

Status

Enrolling

Conditions

Chronic Kidney Disease
Hypertension
Heart Failure
Type 2 Diabetes

Study type

Observational

Funder types

Industry

Identifiers

NCT03549754
D1690R00044

Details and patient eligibility

About

To provide real world data on patient characteristics, disease management, healthcare utilization, and outcomes in patients with type 2 diabetes, Hypertension, Heart failure and/or Chronic kidney diseases

Full description

The registry intends to provide real world data on patient management and quality of care for patients with T2DM, hypertension, heat failure and chronic kidney disease in clinical practice in many countries. To bridge this gap an observational voluntary registry is set up to capture real world data on patient characteristics, disease management, healthcare utilization, and outcomes in patients with type 2 diabetes, Hypertension, Heart Failure and Chronic Kidney Disease. Multinational, observational registry utilizing a cloud-based eCRF, for prospective and retrospective data collection, accessible to investigators and Scientific Committee. This registry will be open to all physicians managing T2DM, HTN, HF or CKD across the world.

Enrollment

35,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Being 18 years or older
  2. Having type 2 diabetes, Hypertension, Heart Failure and/or chronic kidney disease
  3. Providing written informed consent to participate in the registry

Exclusion criteria

  1. Having a life-threatening co-morbidity with life expectancy below 1 year
  2. Participating in an interventional trial requiring informed consent

Trial contacts and locations

54

Loading...

Central trial contact

AstraZeneca Clinical Study Information Center

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems